Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
88 hedge funds and large institutions have $353M invested in Lumos Pharma, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 17 closing their positions.
99% more call options, than puts
Call options by funds: $35.9M | Put options by funds: $18.1M
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 94 → 88 (-6)
10% less capital invested
Capital invested by funds: $394M → $353M (-$40.2M)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ST
Spot Trading
Chicago,
Illinois
|
+$3.44M |
| 2 |
First Eagle Investment Management
New York
|
+$3.28M |
| 3 |
CNB
City National Bank
Beverly Hills,
California
|
+$2.4M |
| 4 |
Millennium Management
New York
|
+$1.26M |
| 5 |
BCM
Bluefin Capital Management
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$8.55M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$7.29M |
| 3 |
PC
PointState Capital
New York
|
-$5.54M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.21M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.86M |
LUMO Hedge Fund Activity: Q2 2014 in Review
88 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2014, worth a combined $353M — down 10% from $394M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of LUMO and 11 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 31 added.
The largest buyer was Spot Trading, opening a new position worth an estimated $3.44M. The largest seller was Invesco, exiting entirely with an estimated $8.55M sold.
- 88 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2014, down from 94 in Q1 2014.
- Funds reported $353M of Lumos Pharma, Inc. Common Stock stock for Q2 2014, down 10% quarter-over-quarter.
- 11 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2014 and 17 closed out, a net change of -6 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q2 2014 was Spot Trading, an estimated $3.44M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q2 2014 was Invesco, an estimated $8.55M sold.
Based on aggregated 13F filings for Q2 2014.